GVK Biosciences appoints Dr. Cecil B. Pickett to scientific advisory board
14 Dec 2009
Hyderabad: Hyderabad-based biotechnology research firm GVK Biosciences has appointed Dr Cecil B. Pickett as scientific advisor to the board of directors.
From March 2006-October 2009, Pickett was president of research and development, and member of the Biogen Idec board of directors. Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions at Schering-Plough Corporation.
As the senior vice president nad president, Schering-Plough Research Institute, Dr Pickett helped bring several large and small molecule candidates into the Schering-Plough clinical development pipeline. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Company.
In addition, Dr. Pickett has served as a member of the US Food and Drug Administration (FDA) science board, the advisory committee to the director of the National Institutes of Health and The National Cancer Policy Board of the Institute of Medicine. He has served as a member of the National Academies Committee on science, engineering and public policy and a member of the Institute of Medicine Forum on Drug Discovery, Development and Translation.
He also sits on the board of directors with Zimmer Holdings Inc, was elected to the Institute of Medicine of the National Academy of Sciences in 1993 and also is a member of The American Society for Cell Biology, American Society of Biochemistry & Molecular Biology, American Association for Cancer Research, and the American Association for the Advancement of Science.
.webp)
